
|Videos|February 9, 2022
INSPIRE and IMvigor011 Trials
Jason Starr, DO, discusses the INSPIRE and IMvigor011 studies that focused on the use of ctDNA in MRD.
Advertisement
Episodes in this series
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss
2
Heart Failure Deaths Shift to Home, Hospice, but Racial Disparities Persist
3
ICYMI: Highlights From ESMO 2025
4
Patients With CKD Are Less Likely to Receive Adjuvant Chemotherapy
5









































